20Ways Winter Hospital 2015

Welcome to interactive presentation, created with Publuu. Enjoy the reading!

WINTER 2015 I HEALTH SYSTEM • INFUSION

WAY

WAY

Contents

20Ways MISSION

To educate pharmacy management on

products and services that serve to improve

patient care or improve a pharmacy’s financial

bottom line, while distilling and presenting this

relevant information via 20 product-profiles.

2015 CIRCULATION

Issue Focus: Hospital & Infusion

Issue Frequency: Summer & Winter

Circulation Per Issue: 19,000+

6,500+ Hospital Directors

2,200+ Clinical Consultants

2,500+ Industry Executives

5,000+ College Preceptors

1,800+ College Faculty

1,000+ Trade Show Handouts

Issue Focus: Retail, Specialty, & LTC

Issue Frequency: Spring, Fall, & Winter

Circulation Per Issue: 35,300+

18,000+ Owners (Independents)

3,500+ Long-Term Care Pharmacies

2,500+ Retail Chain Executives

2,500+ Industry Executives

5,000+ College Preceptors

1,800+ College Faculty

2,000+ Trade Show Handouts

QUARTERLY ISSUES

Visit 20Ways ONLINE at

RXinsider.com/20Ways

Community • Specialty • LTC

20 Unique

Products

& Services

Discover 20 products and

services that will help your

pharmacy improve patient care

or increase profitability.

I M P R O V I N G

PATIENT CARE

& P H A R M A C Y

PROFITABILITY

Fall 2015

Community • Specialty • LTC

Trade Show Calendar

page 46

10 Preceptors

Recognized

10 Preceptors Recognized by Eight

Colleges Including UNC, Union, LIU,

UCONN, Husson and More page 32

Fall 2015

Health System • Infusion

Trade Show Calendar

page 46

20 Unique

Products

& Services

Discover 20 products and

services that will help your

pharmacy improve patient

care or contain costs.

7 Preceptors

Recognized

Seven Preceptors Recognized by Seven

Colleges Including Campbell, UCONN,

MCPHS, Wingate and More page 32

Pharmacist Jobs

Pharmacy Job Opportunities page 62

I M P R O V I N G

P A T I E N T C A R E

PHARMACY COST

C O N T A I N M E N T

Summer 2015

Health System • Infusion

Summer 2015

Community • Specialty • LTC

Trade Show Calendar

page 46

20 Unique

Products

& Services

Discover 20 products and

services that will help your

pharmacy improve patient care

or increase profitability.

7 Preceptors

Recognized

Seven Preceptors Recognized by Seven

Colleges Including Wingate, MCPHS,

Campbell, UCONN, and More page 30

I M P R O V I N G

PATIENT CARE

& P H A R M A C Y

PROFITABILITY

Spring 2015

Community • Specialty • LTC

Spring 2015

Health System • Infusion &

Community • Specialty • LTC

Trade Show Calendar

page 44

20 Unique

Products

& Services

Discover 20 products and

services that will help your

pharmacy improve patient care

or increase profitability.

8 Preceptors

Recognized

Eight Preceptors Recognized by Eight

Colleges Including UNE, LIU, MCPHS,

Union University and More page 28

I M P R O V I N G

PATIENT CARE

& P H A R M A C Y

PROFITABILITY

Winter 2015

Community • Specialty • LTC

Trade Show Calendar

page 56

20 Unique

Products

& Services

Discover 20 products and

services that will help your

pharmacy improve patient

care or contain costs.

8 Preceptors

Recognized

Eight Preceptors Recognized by Eight

Colleges Including UNE, LIU, MCPHS,

Union University and More page 46

Pharmacist Jobs

Pharmacy Job Opportunities page 70

I M P R O V I N G

P A T I E N T C A R E

PHARMACY COST

C O N T A I N M E N T

Winter 2015

Health System • Infusion

Winter 2015

TCGRx is Your

Partner for All

Pharmacy Solutions

TCGRx is a leading supplier of

pharmacy solutions ranging from

individual components to complete

pharmacy design. Including

automated adherence packaging,

unit dose strip packaging, high-

density fixtures, and full perpetual

inventory management.

TCGRx: Integrated Solutions for

Inpatient & Outpatient Pharmacy

www.TCGRx.com info@TCGRx.com 262.279.5307

3 Beacon® Inventory Management

3 ATP

® 2: Barcoded Unit Dose

3 InspectRx™: Unit Dose & Adherence Packaging

Quality Control & Electronic Inspection

3 Outpatient Adherence: 30-Day Discharge

Adherence

3 HDStock™: High-Density Fixtures

Clean Harbors —

Providing Collection

and Disposal

Services for Safe

Hospital Pharmacy

Waste Management

A single container system

that is simple to implement

for clinical staff and is safer

for the environment.

page 29

Go Right to the

Source of Sinus

Problems With

PCCA LoxaSperse™

LoxaSperse is a powder

excipient base for nasal

nebulization and irrigation

compounds that will help your

patients’ medicine go right to

the source of sinus problems.

Connie reclaimed her health – and

her life – from chronic sinus problems.

For patients suffering from chronic, recurrent or resistant

sinus conditions, LoxaSperse™ can be a real game changer.

See how Connie got her life back and get the science behind LoxaSperse at pccarx.com/loxasperse.

LoxaSperse can only be compounded by PCCA Member pharmacies. To find out all the benefits of membership

and see how you can join, visit pccarx.com/join-pcca.

Case study: Connie’s story.

After trying several surgeries and

oral medications, Connie’s doctor

prescribed a compounded nasal

irrigation that has helped clear

up her infection – and helped her

regain her life.

“I feel alive again.”

Connie, a Chronic Sinusitis patient

WAY

Case Study:

Rapivab™

(Peramivir Injection)

Treating acute uncomplicated

influenza with a novel,

one-dose intravenous

neuraminidase inhibitor.

Treating Acute Uncomplicated Infl uenza with a Novel,

One-Dose Intravenous Neuraminidase Inhibitor

THE CHALLENGE:

During the infl uenza season, which typically peaks in the winter months, doctors’ offi ces and

emergency rooms see a great infl ux in patients presenting with infl uenza-like illness. Typically,

the only available treatment option is to prescribe a multi-dose antiviral neuraminidase inhibitor

which can alleviate the symptoms of infl uenza (headache, myalgias, fever, fatigue, cough, sore

throat, and nasal congestion), on average, about a day sooner than standard of care. Many

people are able to quickly recuperate from infl uenza; however, some segments of the population

are at a higher risk of developing serious complications from the fl u, leading to signifi cant

morbidity, hospitalizations, and even death.

THE CASE:

A 62-year-old male smoker with chronic bronchitis who was doing well prior to “catching a

virus” presents with 12-hour history of fever, myalgia, sore throat, cough, and nausea. He states

that he was feeling well the day before, but upon awakening that morning he “felt hot, had a

cough, was nauseated and felt like every single muscle in his body was achy”. He called his

doctor’s offi ce but they were closed and the answering service advised him to go directly to the

emergency department of his local hospital. Upon presentation to the emergency department,

the patient denied any chest pain, dizziness or shortness of breath and reported that he had

not been vaccinated this year for the fl u. He states that he had the fl u a couple years ago and

was given an oral medication but admits he started feeling better a couple days after getting

the prescription and did not complete the treatment course. Patient’s COPD is controlled with

medication, and he does not require supplementary oxygen. His exam was notable for high fever

and muscle aches and his chest X-ray was consistent with chronic COPD but showed no evidence

of pneumonia.

Important Safety Information

Rapivab™ (peramivir injection) is indicated for the treatment of acute uncomplicated infl uenza in patients

18 years and older who have been symptomatic for no more than 2 days.

• Effi cacy of Rapivab was based on clinical trials in which the predominant infl uenza virus type was

infl uenza A; a limited number of subjects infected with infl uenza B virus were enrolled.

• Infl uenza viruses change over time. Emergence of resistance substitutions could decrease drug

effectiveness. Other factors (for example, changes in viral virulence) might also diminish clinical benefi t

of antiviral drugs. Prescribers should consider available information on infl uenza drug susceptibility

patterns and treatment effects when deciding whether to use Rapivab.

• Effi cacy could not be established in patients with serious infl uenza requiring hospitalization.

Case Study

page 22-25

page 27

page 31

Made with Publuu - flipbook maker